Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F de Clerck

Showing results (11-20 of 105) with videos related to

Pageof 11
Sort By:
Archives Internationales De Pharmacodynamie Et De Therapie|August 1, 1975
Effects of suprofen, an inhibitor of prostaglandin biosynthesis, on platelet function, plasma coagulation and fibrinolysis. I. In vitro experimentsF De Clerck, J Vermylen, R Reneman
Thrombosis Research|September 15, 1982
Platelet-mediated vascular contractions: inhibition of the serotonergic component by ketanserinF De Clerck, J M Van Nueten
Coronary Artery Disease|July 1, 1993
The protection by ischemic preconditioning against myocardial ischemia- and reperfusion-induced arrhythmias is not mediated by ATP-sensitive potassium channels in ratsH Lu, P Remeysen, F De Clerck
Archives Internationales De Pharmacodynamie Et De Therapie|September 1, 1975
Effects of suprofen, an inhibitor of prostaglandin biosynthesis, on platelet function, plasma coagulation and fibrinolysis II. In vivo experimentsF De Clerck, J Vermylen, R Reneman
Advances in Cyclic Nucleotide and Protein Phosphorylation Research|January 1, 1984
Vascular reactivity and calcium-entry blockersJ M Van Nueten, F De Clerck
Biochemical Pharmacology|March 1, 1983
Platelet-mediated vascular contractions. Inhibition by flunarizine, a calcium-entry blockerF De Clerck, J M Van Nueten
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1990
Amplification mechanisms in platelet activation and arterial thrombosisF F De Clerck, P A Janssen
Archives Internationales De Pharmacodynamie Et De Therapie|July 1, 1982
Haemorheological effects of ketanserin, a selective 5-HT2 receptor antagonist, in aged, spontaneously hypertensive dogsF De Clerck, A Jageneau, J Dom
Federation Proceedings|February 1, 1983
5-hydroxytryptamine and platelet aggregationF F De Clerck, A G Herman
Cardiovascular Research|May 4, 2001
Phase 2 prolongation, in the absence of instability and triangulation, antagonizes class III proarrhythmiaL M Hondeghem, K Dujardin, F De Clerck
Pageof 11

Showing results (11-20 of 105) with videos related to

Sort By:
Pageof 11
Archives Internationales De Pharmacodynamie Et De Therapie|August 1, 1975
Effects of suprofen, an inhibitor of prostaglandin biosynthesis, on platelet function, plasma coagulation and fibrinolysis. I. In vitro experimentsF De Clerck, J Vermylen, R Reneman
Thrombosis Research|September 15, 1982
Platelet-mediated vascular contractions: inhibition of the serotonergic component by ketanserinF De Clerck, J M Van Nueten
Coronary Artery Disease|July 1, 1993
The protection by ischemic preconditioning against myocardial ischemia- and reperfusion-induced arrhythmias is not mediated by ATP-sensitive potassium channels in ratsH Lu, P Remeysen, F De Clerck
Archives Internationales De Pharmacodynamie Et De Therapie|September 1, 1975
Effects of suprofen, an inhibitor of prostaglandin biosynthesis, on platelet function, plasma coagulation and fibrinolysis II. In vivo experimentsF De Clerck, J Vermylen, R Reneman
Advances in Cyclic Nucleotide and Protein Phosphorylation Research|January 1, 1984
Vascular reactivity and calcium-entry blockersJ M Van Nueten, F De Clerck
Biochemical Pharmacology|March 1, 1983
Platelet-mediated vascular contractions. Inhibition by flunarizine, a calcium-entry blockerF De Clerck, J M Van Nueten
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1990
Amplification mechanisms in platelet activation and arterial thrombosisF F De Clerck, P A Janssen
Archives Internationales De Pharmacodynamie Et De Therapie|July 1, 1982
Haemorheological effects of ketanserin, a selective 5-HT2 receptor antagonist, in aged, spontaneously hypertensive dogsF De Clerck, A Jageneau, J Dom
Federation Proceedings|February 1, 1983
5-hydroxytryptamine and platelet aggregationF F De Clerck, A G Herman
Cardiovascular Research|May 4, 2001
Phase 2 prolongation, in the absence of instability and triangulation, antagonizes class III proarrhythmiaL M Hondeghem, K Dujardin, F De Clerck
Pageof 11